Pre-clinical evaluation of 225Ac-DOTATOC pharmacokinetics, dosimetry, and toxicity to enable Phase-1 clinical trial in patients with neuroendocrine tumors
Title:
Pre-clinical evaluation of 225Ac-DOTATOC pharmacokinetics, dosimetry, and toxicity to enable Phase-1 clinical trial in patients with neuroendocrine tumors
Author:
Norenberg, J. Anderson, T. Hesterman, J. Orcutt, K. Nysus, M. Kusewitt, D. Fair, J. Soares, H. John, K. Rixe, O.